Trust Company of the Ozarks’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.35M Sell
9,774
-180
-2% -$28.4K 0.47% 49
2015
Q2
$1.53M Sell
9,954
-136
-1% -$21.8K 0.42% 46
2015
Q1
$1.61M Sell
10,090
-63
-0.6% -$9.92K 0.42% 40
2014
Q4
$1.62M Buy
10,153
+185
+2% +$28.8K 0.45% 39
2014
Q3
$1.4M Sell
9,968
-44
-0.4% -$5.75K 0.39% 47
2014
Q2
$1.19M Buy
10,012
+615
+7% +$71.2K 0.32% 58
2014
Q1
$1.16M Sell
9,397
-815
-8% -$98.8K 0.33% 56
2013
Q4
$1.17M Sell
10,212
-300
-3% -$34.1K 0.33% 53
2013
Q3
$1.18M Hold
10,512
0.37% 52
2013
Q2
$1.04M Buy
+10,512
New +$1.09M 0.34% 55

Other funds holding AMGN

Trust Company of the Ozarks's AMGN Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its Amgen (AMGN) stake by 1.8% in Q3 2015, selling an estimated $28.4K and leaving 9,774 shares worth $1.35M. The position accounts for 0.47% of the portfolio, ranked #49.

Trust Company of the Ozarks first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.62M in Q4 2014. 1,381 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Trust Company of the Ozarks held 9,774 shares of Amgen worth $1.35M as of Q3 2015.
  • Trust Company of the Ozarks sold 180 Amgen shares in Q3 2015, an estimated $28.4K.
  • Amgen made up 0.47% of Trust Company of the Ozarks's portfolio in Q3 2015, its #49 holding.
  • Trust Company of the Ozarks first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • Trust Company of the Ozarks's Amgen position peaked at $1.62M in Q4 2014.
  • 1,381 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.